Cannabinoids in Health and Disease
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 5816
Special Issue Editors
Interests: bioactive molecules; drug design and synthesis; endocannabinoid system modulators; neurodegenerative diseases; anticancer agents; anti-inflammatory activity
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The research in the field of cannabinoids was initially associated with the active principles present in the Cannabis plant, which were identified in the first 70 years of the past century, with the discovery of Δ9-tetrahydrocannabinol (Δ9-THC), the major psychoactive ingredient of the Cannabis plant, in 1964. However, it was the discovery of cannabinoid receptors, their endogenous ligands (endocannabinoids), and enzymes whose discovery occurred in the 1980s–1990s, that provided the basis for further developments in cannabinoid research. Since then, the (patho)physiology of this system has been a very active research area focused on exploring its function in numerous physiological processes in the CNS and its periphery, and, in particular, on elucidating its therapeutic value in numerous disorders.
The purpose of this Special Issue is to publish original research papers, and relevant updates of literature data, on the beneficial effects of cannabinoids in many pathologic conditions, with the aim of highlighting the diversity and innovation of this research field for novel therapeutic applications.
Dr. Clementina Manera
Dr. Simone Bertini
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Endocannabinoid system
- Cannabinoid receptors
- Endocannabinoids
- Phytocannabinoids
- Synthetic cannabinoids
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
